Space Flight Ophthalmic Changes, Diet, and Vitamin Metabolism

Handbook of Nutrition, Diet and the Eye

Volumn , Issue , 2014, Pages 393-399

  Zwart, S R ^a   Gibson, C R ^b,c   Smith, S M ^d  

^a UNIVERSITIES SPACE RESEARCH ASSOCIATION   (United States)

^b WYLE LABORATORIES   (United States)

^c Coastal Eye Associates ^*  (United States)

^d NASA JOHNSON SPACE CENTER   (United States)

Author keywords

Folate; Homocysteine; One carbon metabolism; Space flight; Vision

Indexed keywords

EID: 84943302579     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-401717-7.00040-X     Document Type: Chapter

References (35)

1. Rastegar N., Eckart P., Mertz M. Radiation-induced cataract in astronauts and cosmonauts. Graefes Arch Clin Exp Ophthalmol 2002, 240:543-547.
2. Cucinotta F.A., Manuel F.K., Jones J., Iszard G., Murrey J., Djojonegro B., Wear M. Space radiation and cataracts in astronauts. Radiat Res 2001, 156:460-466.
3. Chylack L.T., Peterson L.E., Feiveson A.H., Wear M.L., Manuel F.K., Tung W.H., et al. NASA study of cataract in astronauts (NASCA). Report 1: Cross-sectional study of the relationship of exposure to space radiation and risk of lens opacity. Radiat Res 2009, 172:10-20.
4. Jones J.A., McCarten M., Manuel K., Djojonegoro B., Murray J., Feiversen A., Wear M. Cataract formation mechanisms and risk in aviation and space crews. Aviat Space Environ Med 2007, 78(4 Suppl):A56-A66.
5. Chylack L.T., Feiveson A.H., Peterson L.E., Tung W.H., Wear M.L., Marak L.J., et al. NASCA Report 2: Longitudinal study of relationship of exposure to space radiation and risk of lens opacity. Radiat Res 2012, 178:25-32.
6. Agte V., Tarwadi K. The importance of nutrition in the prevention of ocular disease with special reference to cataract. Ophthalmic Res 2010, 44:166-172.
7. Mader T.H., Gibson C.R., Pass A.F., Kramer L.A., Lee A.G., Fogarty J., et al. Optic disc edema, globe flattening, choroidal folds, and hyperopic shifts observed in astronauts after long-duration space flight. Ophthalmology 2011, 118:2058-2069.
8. Mayasnikov V.I., Stepanova S.I. Features of cerebral hemodynamics in cosmonauts before and after flight on the MIR Orbital Station. Orbital Station MIR Institute of Biomedical Problems: State Scientific Center of Russian Federation 2008, 300-305.
9. Smith S.M., Zwart S.R., Kloeris V., Heer M. Nutritional Biochemistry of Space Flight 2009, Nova Science Publishers, New York.
10. Smith S.M., Krauhs J.M., Leach C.S. Regulation of body fluid volume and electrolyte concentrations in spaceflight. Adv Space Biol Med 1997, 6:123-165.
11. Mader T.H., Gibson C.R., Caputo M., Hunter N., Taylor G., Charles J., Meehan R.T. Intraocular pressure and retinal vascular changes during transient exposure to microgravity. Am J Ophthalmol 1993, 115:347-350.
12. Draeger J., Schwartz R., Groenhoff S., Stern C. Self-tonometry under microgravity conditions. Aviat Space Environ Med 1995, 66:568-570.
13. Manuel F.K., Mader T.H. Ophthalmologic considerations. Principles of Clinical Medicine for Space Flight 2008, 535-544. Springer, New York. M.R. Barratt, S.L. Pool (Eds.).
14. Zwart S.R., Gibson C.R., Mader T.H., Ericson K., Ploutz-Snyder R., Heer M., Smith S.M. Vision changes after spaceflight are related to alterations in folate- and vitamin B12-dependent one-carbon metabolism. J Nutr 2012, 142:427-431.
15. Herrmann W., Schorr H., Purschwitz K., Rassoul F., Richter V. Total homocysteine, vitamin B(12), and total antioxidant status in vegetarians. Clin Chem 2001, 47:1094-1101.
16. Bailey L.B., Gregory J.F. Folate. Present Knowledge in Nutrition 2006, 278-301. International Life Sciences Institute, Washington, DC. 9th ed. B.A. Bowman, R.M. Russell (Eds.).
17. Stabler S.P. Vitamin B12. Present Knowledge in Nutrition 2006, 302-313. International Life Sciences Institute, Washington, DC. 9th ed. B.A. Bowman, R.M. Russell (Eds.).
18. Wilcken B., Bamforth F., Li Z., Zhu H., Ritvanen A., Renlund M., et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet. 2003, 40:619-625.
19. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995, 10:111-113.
20. Davis S.R., Quinlivan E.P., Shelnutt K.P., Maneval D.R., Ghandour H., Capdevila A., et al. The methylenetetrahydrofolate reductase 677C→T polymorphism and dietary folate restriction affect plasma one-carbon metabolites and red blood cell folate concentrations and distribution in women. J Nutr 2005, 135:1040-1044.
21. Shelnutt K.P., Kauwell G.P., Chapman C.M., Gregory J.F., Maneval D.R., Browdy A.A., et al. Folate status response to controlled folate intake is affected by the methylenetetrahydrofolate reductase 677C→T polymorphism in young women. J Nutr 2003, 133:4107-4111.
22. Imamura A., Okumura K., Matsui H., Mizuno T., Ogawa Y., Imai H., et al. Endothelial nitric oxide synthase and methylenetetrahydrofolate reductase gene polymorphisms are associated with endothelial dysfunction in young, healthy men. Can J Cardiol 2004, 20:1229-1234.
23. Oterino A., Toriello M., Valle N., Castillo J., Alonso-Arranz A., Bravo Y., et al. The relationship between homocysteine and genes of folate-related enzymes in migraine patients. Headache 2010, 50:99-168.
24. Kowa H., Yasui K., Takeshima T., Urakami K., Sakai F., Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000, 96:762-764.
25. Cronin S., Furie K.L., Kelly P.J. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 2005, 36:1581-1587.
26. Solis C., Veenema K., Ivanov A.A., Tran S., Li R., Wang W., et al. Folate intake at RDA levels is inadequate for Mexican American men with the methylenetetrahydrofolate reductase 677TT genotype. J Nutr 2008, 138:67-72.
27. Chu C., Scanlon P. Vitamin B12 deficiency optic neuropathy detected by asymptomatic screening. BMJ Case Rep 2011.
28. Chavala S.H., Kosmorsky G.S., Lee M.K., Lee M.S. Optic neuropathy in vitamin B12 deficiency. Eur J Intern Med 2005, 16:447-448.
29. de Silva P., Jayamanne G., Bolton R. Folic acid deficiency optic neuropathy: a case report. J Med Case Rep 2008, 2:299.
30. Mojon D.S., Kaufmann P., Odel J.G., Lincoff N.S., Marquez-Fernandez M., Santiesteban R., et al. Clinical course of a cohort in the Cuban epidemic optic and peripheral neuropathy. Neurology 1997, 48:19-22.
31. Sbeity Z.H., Baydoun L., Schmidt S., Loeffler K.U. Visual field changes in methotrexate therapy. Case report and review of the literature. J Med Liban 2006, 54:164-167.
32. Clare G., Colley S., Kennett R., Elston J.S. Reversible optic neuropathy associated with low-dose methotrexate therapy. J Neuroophthalmol 2005, 25:109-112.
33. Endresen G.K., Husby G. Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines. Scand J Rheumatol 2001, 30:129-134.
34. van Ede A.E., Laan R.F., Blom H.J., Boers G.H., Haagsma C.J., Thomas C.M., et al. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology (Oxford) 2002, 41:658-665.
35. Candito M., Candito E., Chatel M., van Obberghen E., Dunac A. Homocysteinemia and thrombophilic factors in unexplained decompression sickness. Rev Neurol (Paris) 2006, 162:840-844.